详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Tianjin Med Univ Canc Inst & Hosp, Dept Gastrointestinal Med Oncol, Tianjin, Peoples R China [2]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China [3]Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China [4]Wuhan Univ, Dept Gastrointestinal Surg, Zhongnan Hosp, Wuhan, Peoples R China [5]Wuhan Univ, Zhongnan Hosp, Dept Gastr & Colorectal Surg Oncol, Wuhan, Peoples R China [6]Harbin Med Univ, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China [7]Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China [8]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China [9]Hebei Med Univ, Hosp 4, Dept Surg 3, Shijiazhuang, Peoples R China [10]Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China [11]Qilu Hosp Shandong Prov, Jinan, Peoples R China [12]Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China [13]Nanjing Univ, Drum Tower Hosp, Dept Gen Surg, Med Sch, Nanjing, Peoples R China [14]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China [15]Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China [16]Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China [17]Wannan Med Coll, Affiliated Hosp 1, Wuhu, Anhui, Peoples R China [18]Sichuan Prov Canc Hosp Inst, Chengdu, Sichuan, Peoples R China [19]Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China [20]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China [21]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China

出处：

DOI：

ISSN：

关键词： 3282-206-2713-2693 283-237-255 613-135-2370-7650-2700 283-11574 3282-206-2497-2540-2595 613-135-2370-7650-2454 613-213-2711-3371 5 4 3 2 38092-20390

语种：

WOS：

中科院(CAS)分区：

出版当年[2024]版：

无

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

影响因子： 42.1 最新[2023版] 37.4 最新五年平均 42.1 出版当年[2023版] 0 出版当年五年平均 42.1 出版前一年[2023版]

第一作者：

第一作者机构： [2]Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Discovery of 4-((3 ' R,4 ' S,5 ' R)-6 ''-Chloro-4 '-(3-chloro-2-fluorophenyl)-1 '-ethyl-2 ''-oxodispiro[cyclohexane-1,2 '-pyrrolidine-3 ',3 ''-indoline]-5 '-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development [2]First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study [3]First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study [4]Ultrasound-guided microwave ablation for giant breast leiomyoma: A case report [5]KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation [6]Phase II clinical study evaluating the efficacy and safety of disitamab vedotin combined with sintilimab and S-1 in the conversion treatment of HER2-overexpression unresectable gastric cancer [7]Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis [8]Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. [9]Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer [10]Design, Synthesis, and Antitumor Activity Evaluation of 2-Phenylthiazole-5-Carboxylic Acid Derivatives Targeting Transactivation Response RNA-Binding Protein 2